SCHEMBL3946067

SCHEMBL3946067

O=Cc1c(I)cc(Br)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 1/20 0.42
MCL1 Q07820 1/20 0.38
ERN1 O75460 4/20 0.35
GSK3B P49841 1/20 0.33
MAPT P10636 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
AHR P35869 1/20 0.33
ALDH1A1 P00352 5/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PRNP P04156 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4E B2RXH2 1/20 0.32
THRB P10828 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3268788 0.77 PADI4 (0.42) PADI4ERN1MAPTMEN1KMT2A
SCHEMBL29588097 0.71 PADI4 (0.64) PADI4ERN1MAPTMEN1KMT2A
SCHEMBL986883 0.71 PADI4 (0.64) PADI4ERN1MAPTMEN1KMT2A
SCHEMBL9838932 0.71 PADI4 (0.44) PADI4ERN1GSK3BMAPTMEN1
SCHEMBL10488301 0.70 PADI4 (0.52) PADI4ERN1GSK3BMAPTMEN1
SCHEMBL31179408 0.69 CTSB (0.42) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL19063389 0.69 ALDH1A1 (0.35) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL3268207 0.69 PADI4 (0.42) PADI4ERN1GSK3BMAPTMEN1
SCHEMBL3371061 0.69 PADI4 (0.52) PADI4MCL1ERN1GSK3BMAPT
SCHEMBL15104846 0.69 ALDH1A1 (0.43) PADI4ERN1GSK3BMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049481-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-04-22 EP disclosed
WO-2008021851-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed